female sexual dysfunction. Sexual dysfunction, not caused by organic disorder or disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria : Women ages 18-50 years; Diagnosis low sexual desire by using the FSFI ( Female Sexual Function Index ); Emotionally satisfying relationship with constant wife sexually active at least one year; Having sex at least once a month; Lack of pregnancy and lactation; No menstruation retard for 2 months and more ; Normal genital examination. Exclusion criteria : Impaired emotionally satisfying relationship with wife ; Adding another partner in the study period; Any organic disease, anatomical and hormonal that exist in history and past medical history, including : diabetes , cerebrovascular disease , liver and kidney damage , heart disease , hypothyroidism, cancer; Psychiatric disorders who are under medical treatment; Smoking , alcohol , drug abuse; Use of any chemical and herbal medications that affect sexual desire.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sexual desire. Timepoint: Baseline, 4 and 8 weeks after starting the medication. Method of measurement: Questionnaire Female Sexual Function Index. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sexual arousal. Timepoint: Baseline, 4 and 8 weeks after starting the medication. Method of measurement: Questionnaire Female Sexual Function Index.;Sexual Satisfaction. Timepoint: Baseline, 4 and 8 weeks after starting the medication. Method of measurement: Questionnaire Female Sexual Function Index.;Obvious distress caused by sexual dysfunction. Timepoint: Baseline, 4 and 8 weeks after starting the medication. Method of measurement: Question of patients.;Painful intercourse. Timepoint: Baseline, 4 and 8 weeks after starting the medication. Method of measurement: Questionnaire Female Sexual Function Index.;Moisture of genitalia. Timepoint: Baseline, 4 and 8 weeks after starting the medication. Method of measurement: Questionnaire Female Sexual Function Index.;Increased frequency of sexual intercourse. Timepoint: Baseline, 4 and 8 weeks after starting the medication. Method of measurement: Question of patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahed University of Medical Sciences